Clinical Trials Logo

Vocal Fold Palsy clinical trials

View clinical trials related to Vocal Fold Palsy.

Filter by:
  • None
  • Page 1

NCT ID: NCT05747859 Completed - Vocal Fold Palsy Clinical Trials

Voice Telerehabilitation

Start date: November 5, 2021
Phase:
Study type: Observational

The aim of the study was to determine functional results of telerehabilitation (TR) in subjects affected by iatrogenic unilateral vocal fold paralysis (UVFP) during the COVID-19 pandemic outbreak. 40 patients with iatrogenic unilateral vocal fold paralysis underwent voice teletherapy with a synchronous approach. A multidimensional assessment by means of videolaryngostroboscopy, acoustic and perceptual analysis and patient self-assessment was carried out before, at the end of teletherapy and six months later.

NCT ID: NCT04764604 Completed - Dysphonia Clinical Trials

Evaluating the Feasibility of Acapella® Choice as a Dysphonia Treatment

Start date: December 14, 2020
Phase: N/A
Study type: Interventional

A feasibility study to identify the immediate effect on the voices of patients with voice disorders (muscle tension dysphonia, vocal fold palsy or presbylaryngis) produced by exercising with Acapella Choice as a form of semioccluded vocal tract exercise (SOVTE).

NCT ID: NCT04700566 Recruiting - Vocal Fold Palsy Clinical Trials

Allograft Adipose Injectable for Vocal Fold Paralysis

Start date: May 16, 2022
Phase: Phase 3
Study type: Interventional

Renuva is allograft adipose matrix commonly used as a filler in cosmetic procedures. The investigators are studying this material as an injectable in the vocal fold to treat glottic insufficiency. Currently, many products can be used as an injectable in the vocal fold to correct glottic insufficiency such as carbomethycellulose, hyaluronic acid, collagen derivatives and calcium hydroxyapatite amongst others. An ideal injectable would not impair the fibroelastic property of the vocal fold tissues and would integrate within the tissue of the vocal fold. Since Renuva has the property of stimulating adipogenesis by using growth factor and collagen, the investigators believe it could represent a good option in terms of safety and efficacy for vocal fold augmentation. This study will assess the safety and efficacy of Renuva as a vocal fold injectable to treat glottic insufficiency.

NCT ID: NCT04315415 Completed - Clinical trials for Vocal Cord Paralysis

A Histological Study Evaluating Silk Voice and Crosslinked Hyaluronic Acid

Start date: January 15, 2020
Phase: N/A
Study type: Interventional

The primary study goal is to evaluate the histological characteristic of Silk Voice to evaluate the potential for Silk Voice to deliver long-term results to patients.

NCT ID: NCT03882450 Completed - Dysphagia Clinical Trials

Universal Screening for Vocal Fold Motion Impairment in Children Undergoing Congenital Cardiac Surgery

Start date: January 1, 2019
Phase: N/A
Study type: Interventional

The purpose of this study is to determine how often heart or chest surgery in children leads to problems with the movement of the vocal folds.

NCT ID: NCT01501526 Recruiting - Vocal Fold Palsy Clinical Trials

Unusual Clinical Findings of Herpes Esophagitis

Start date: October 2011
Phase: N/A
Study type: Observational

Herpes esophagitis presents a clinical diagnostic challenge. The investigators report the first case of herpes esophagitis presenting as vocal fold palsy in an immunocompetent host. The investigators case highlights the importance of performing a detailed laryngoscopic examination in any patient with prolonged husky voice.